All Posts: News Release
-
Large Federal Program Aimed at Providing Better Health Care Underfunds Primary Care
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (Apri 16, 2019) — Despite a mandate to help patients make better-informed health care decisions, a 10-year research program established under the Affordable Care Act has funded a relatively small number of studies that examine primary care, the setting where the majority of patients in the U.S. receive treatment. The finding, […]
Category: News Release
-
Rare but Important Gene Target Found in Many Tumor Types, Suggesting New Therapy Possible
Category: News Release
-
Georgetown Welcomes Deus Bazira and Colleagues to Lead New Global Health Center
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (April 15, 2019) — Georgetown University Medical Center (GUMC) announces the appointment of Deus Bazira, DrPH, MPH, MBA, BPharm, an expert in health systems strengthening and a public health practitioner with decades of in-depth field-level practical experience in global health in emerging economies, to establish and co-direct Georgetown’s new Center for […]
Category: News Release
-
Georgetown Global Health Experts in Infectious Disease Available to Comment on WHO PHEIC Meeting
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (April 12, 2019) — Today, World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus, on the recommendation of the Emergency Committee, declined to declare the Ebola outbreak in the Democratic Republic of Congo a Public Health Emergency of International Concern (PHEIC). Global health security expert Rebecca Katz, PhD, MPH, and global health […]
Category: News Release
-
Personalized Medicine Clinical Trial Underway for Type of Incontinence Common in Women
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (April 2, 2019) — A novel clinical trial aims to reverse the cause of a common problem among older women — accidental urine leakage — by using a patient’s own muscle cells. The study, now underway in the Washington area, is for women with stress urinary incontinence. Stress urinary incontinence, or […]
Category: News Release
-
Georgetown Lombardi Director Louis Weiner Receives AACR 2019 Distinguished Public Service Award
Category: News Release
-
Novel Brain Map Tracks Early Brain Atrophy From HIV Infection
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 28, 2019) — A new map of brain tissue in people with HIV shows atrophy in several areas including a primary neurocognitive control center where shrinkage and loss of function can be seen in scans before clinical symptoms appear. The map and other findings from researchers at Georgetown University Medical […]
Category: News Release
-
A Billion People Will Be Newly Exposed to Diseases Like Dengue Fever as World Temperatures Rise
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 28, 2019) — As many as a billion people could be newly exposed to disease-carrying mosquitoes by the end of the century because of global warming, says a new study that examines temperature changes on a monthly basis across the world. Scientists say the news is bad even in areas […]
Category: News Release
-
Georgetown Researchers Launch ‘Nari Paila,’ Mobile Games to Share Information on Fertility Awareness, Family Planning in Nepal
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 24, 2019) — This month, Georgetown researchers launched a series of mobile games in Nepal to reach young people with information about fertility awareness and family planning. The mobile games, called “Nari Paila” (“Women First”), were developed in collaboration with Gaming Revolution for Inspiring Development (GRID). The games integrate information […]
Category: News Release
-
Georgetown-Led Study Leads to First FDA-Approved Drug in Decades to Improve Survival in Small Cell Lung Cancer
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 18, 2019) — The U.S. Food and Drug Administration’s approval today of atezolizumab (Tecentriq®, Genentech) in combination with chemotherapy (carboplatin and etoposide) for the initial treatment of extensive-stage small cell lung cancer (SCLC) marks the end of numerous failed attempts to improve survival for those with the deadly disease. “Atezolizumab, […]
Category: News Release